Send us Feedback

Peregrine Pharmaceuticals (PPHM)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Timing the Markets: Why 2012 is a Key Year
Invest2Success  Mar 1  Comment 
Click Here To Review the Financial Forecast Service Fibonacci numbers follow a sequence that begins with 0 and 1, and each subsequent number is the sum of the previous two (0,1,1,2,3,5,8,13,21,34,55,89,144 and so on). This famous sequence...
Peregrine to Report Third Quarter Fiscal Year 2012 Financial Results After Market on March 9, 2012
Marketwire  Mar 1  Comment 
TUSTIN, CA -- (Marketwire) -- 03/01/12 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today announced
Peregrine Announces Seven Abstracts Accepted for Presentation at AACR 2012 Annual Meeting
Marketwire  Mar 1  Comment 
TUSTIN, CA -- (Marketwire) -- 03/01/12 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and infectious diseases, today announced
Peregrine Announces Participation at Upcoming Investor Conferences in March
Marketwire  Feb 27  Comment 
TUSTIN, CA -- (Marketwire) -- 02/27/12 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and infectious diseases, today announced
Avid Bioservices to Present at IBC's Antibody Development and Production Conference
Marketwire  Feb 23  Comment 
TUSTIN, CA and SAN DIEGO, CA -- (Marketwire) -- 02/23/12 -- Avid Bioservices, Inc., a leading provider of integrated biomanufacturing services and a subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that it will present
RF Micro (RFMD) Responds to Patent Suit by Peregrine Semi
StreetInsider.com  Feb 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/RF+Micro+%28RFMD%29+Responds+to+Patent+Suit+by+Peregrine+Semi/7188157.html for the full story.
Peregrine Files Patent Infringement Actions Against RF Micro Devices and Motorola Mobility
Cellular News  Feb 15  Comment 
Radio-frequency (RF) integrated circuits vendor, Peregrine Semiconductor has filed a complaint and a lawsuit alleging the infringement of RFICs and switching technology patents by RF Micro Devices (RFMD) and Motorola Mobility. Click here for more.
Peregrine to Present at BIO CEO and Investor Conference on Tuesday, February 14, 2012 at 8:30 AM EST
Marketwire  Feb 9  Comment 
TUSTIN, CA -- (Marketwire) -- 02/09/12 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and infectious diseases, today announced
Movers & Shakers: Thursday’s biggest gaining and declining stocks
MarketWatch  Dec 29  Comment 
MarketWatch’s daily rundown of shares that made sizable moves in the U.S. stock market.
UPDATE: Peregrine Says Preliminary Data From Phase II Study Shows Antiviral Activity and Positive Safety Profile at Both Bavituximab Doses Evaluated
Benzinga  Dec 29  Comment 
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Peregrine_Pharmaceuticals_(PPHM)"
Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki